6 stories about Fitch
כוחות צה"ל ב חאן יונס 27.3.24 מלחמת עזה 2

Fitch reaffirms Israel's A+ rating, removes Negative Watch

Fitch ratings' outlook for Israel remains negative to "reflect the combination of uncertainties around the fiscal trajectory and the war's duration and intensity, including the risk of regional escalation."
העיר תל אביב מלמעלה  זירת הנדל"ן

Fitch Affirms Israel’s A+ Rating, Citing Strong Growth

01.09.19|Omri Milman
The credit rating agency affirmed the rating with a stable outlook, estimating the deficit will grow to 3.6% of GDP in 2019, in line with the forecasts of the Israeli Ministry of Finance
אתר טבע כפר סבא

Fitch Downgrades Teva, Keeps Outlook at Negative

10.06.19|Hezi Sternlicht
Fitch pins the downgrade on the drugmaker's slow revenue growth, persisting cost challenges and downward pressure on generic drug prices, and the company's legal trouble in the U.S.
תל אביב קו רקיע Tel Aviv Skyline

High Government Debt Countered by Strong Finances Leads Fitch to Affirm Israel's A+ Rating

26.03.19|Lilach Baumer
Israel scores above the median on GDP growth and human development indicators, but low on government budget deficit, government debt, and ease of doing business
מדענית ב מעבדת אבטחת איכות של חברת טבע TEVA

JPMorgan Downgrades Teva’s Stock to Underweight

13.11.17|Amarelle Wenkert
Christopher Schott, managing director at JPMorgan, said that the decision to downgrade is based on the challenges facing Teva’s generic drug unit
מטה טבע פתח תקווה

Fitch Downgrades Teva to Junk Rating

07.11.17|Yaniv Rahimi
The U.S. credit agency changed Teva's rating from BBB to BB, with a negative outlook, due to "significant operational stress." The downgrade might affect Teva's ability to take on additional debt